Heterogeneity and lack of standardisation in gut microbiome testing: a comparative assessment of French medical biology laboratories - Top-Institutions - MDSpire

Heterogeneity and lack of standardisation in gut microbiome testing: a comparative assessment of French medical biology laboratories

  • By

  • Maxime Pichon

  • Claire Bouleti

  • MICMAC Study Group SFM

  • Genevieve Hery-Arnaud

  • Christophe Burucoa

  • July 1, 2026

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Broad Institute of MIT and Harvard
    Broad Institute of MIT and Harvard

    Cambridge, Massachusetts

    Key Differentiators

    • Microbiology
    • Genomics

  • #2

    Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of Medicine

    St. Louis, Missouri

    Key Differentiators

    • Gastroenterology
    • Microbiology

  • #3

    Henri Mondor Hospital
    Henri Mondor Hospital

    Créteil, France

    Key Differentiators

    • Medical Biology
    • Gastroenterology

  • #4

    Shiga University of Medical Science
    Shiga University of Medical Science

    Shiga, Japan

    Key Differentiators

    • Gastroenterology
    • Medical Biology

  • #5

    Universidad San Francisco de Quito
    Universidad San Francisco de Quito

    Quito, Ecuador

    Key Differentiators

    • Medical Biology
    • Gastroenterology

Original Source(s)

Heterogeneity and lack of standardisation in gut microbiome testing: a comparative assessment of French medical biology laboratories

  • by Maxime Pichon, Claire Bouleti, MICMAC Study Group SFM, Genevieve Hery-Arnaud, Christophe Burucoa

  • July 1, 2026

Related Content

Endoscopic treatment outcomes for foreign body extraction from alimentary tract: a 15-year experience of 1,162 cases in Southern China

Harnessing AI-driven approaches for detecting metabolic dysfunction-associated steatotic liver disease, assessing fibrosis, and stratifying hepatocellular carcinoma risk: a scoping review

Microbiome dysbiosis and its modulation in cancer development, prevention and therapy